Clinical Trial Update: Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance Insomnia Followed by Optional Extension up to 1 Year [Phase 3]

View source ↗

Summary

Phase 3 trial assessing efficacy and safety of eplivanserin for sleep maintenance insomnia, with an optional extension up to one year, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• Eplivanserin (Eplivanserin)

Snippet

Sponsor: Sanofi | Conditions: Sleep Initiation and Maintenance Disorders, Insomnia | Phase 3 | Status: COMPLETED